Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
3.380
-0.053 (-1.55%)
At close: Aug 15, 2025, 4:00 PM
3.350
-0.030 (-0.89%)
After-hours: Aug 15, 2025, 4:46 PM EDT
Galecto Market Cap
Galecto has a market cap or net worth of $4.48 million as of August 15, 2025. Its market cap has decreased by -70.57% in one year.
Market Cap
4.48M
Enterprise Value
-5.62M
1-Year Change
-70.57%
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $4.48M, a decrease of -98.79%. That is a compound annual growth rate of -60.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 4.55M | -25.74% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
| Oct 29, 2020 | 368.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |